X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $6.01 per share a year ago.